Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Atricure Inc (ATRC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 805,973
  • Shares Outstanding, K 33,950
  • Annual Sales, $ 155,110 K
  • Annual Income, $ -33,340 K
  • 36-Month Beta 0.79
  • Price/Sales 5.22
  • Price/Cash Flow 0.00
  • Price/Book 5.04

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.68 +4.67%
on 06/22/17
25.11 -5.46%
on 07/12/17
+0.96 (+4.21%)
since 06/21/17
3-Month
19.77 +20.08%
on 04/24/17
25.11 -5.46%
on 07/12/17
+4.19 (+21.43%)
since 04/21/17
52-Week
13.45 +76.51%
on 08/08/16
25.11 -5.46%
on 07/12/17
+8.50 (+55.77%)
since 07/21/16

Most Recent Stories

More News
AtriCure to Present at the Canaccord Genuity 37th Annual Growth Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it...

ATRC : 23.74 (-0.54%)
Uptrend Call Working As Atricure Inc Stock Rises 44.4% (ATRC)

SmarTrend identified an Uptrend for Atricure Inc (NASDAQ:ATRC) on February 15th, 2017 at $17.21. In approximately 5 months, Atricure Inc has returned 44.43% as of today's recent price of $24.85.

ATRC : 23.74 (-0.54%)
Atricure Inc Up 41.8% Since SmarTrend Uptrend Call (ATRC)

SmarTrend identified an Uptrend for Atricure Inc (NASDAQ:ATRC) on February 15th, 2017 at $17.21. In approximately 5 months, Atricure Inc has returned 41.82% as of today's recent price of $24.40.

ATRC : 23.74 (-0.54%)
AtriCure to Announce Second Quarter 2017 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release...

ATRC : 23.74 (-0.54%)
AtriCure Up 32.1% Since SmarTrend Uptrend Call (ATRC)

SmarTrend identified an Uptrend for AtriCure (NASDAQ:ATRC) on February 15th, 2017 at $17.21. In approximately 4 months, AtriCure has returned 32.11% as of today's recent price of $22.73.

ATRC : 23.74 (-0.54%)
AtriCure Shares Up 24.4% Since SmarTrend's Buy Recommendation (ATRC)

SmarTrend identified an Uptrend for AtriCure (NASDAQ:ATRC) on February 15th, 2017 at $17.21. In approximately 4 months, AtriCure has returned 24.38% as of today's recent price of $21.40.

ATRC : 23.74 (-0.54%)
AtriCure Shares Up 24.4% Since SmarTrend's Buy Recommendation (ATRC)

SmarTrend identified an Uptrend for AtriCure (NASDAQ:ATRC) on February 15th, 2017 at $17.21. In approximately 4 months, AtriCure has returned 24.38% as of today's recent price of $21.40.

ATRC : 23.74 (-0.54%)
AtriCure Shares Up 24.4% Since SmarTrend's Buy Recommendation (ATRC)

SmarTrend identified an Uptrend for AtriCure (NASDAQ:ATRC) on February 15th, 2017 at $17.21. In approximately 4 months, AtriCure has returned 24.38% as of today's recent price of $21.40.

ATRC : 23.74 (-0.54%)
AtriCure Shares Up 25.1% Since SmarTrend's Buy Recommendation (ATRC)

SmarTrend identified an Uptrend for AtriCure (NASDAQ:ATRC) on February 15th, 2017 at $17.21. In approximately 3 months, AtriCure has returned 25.14% as of today's recent price of $21.53.

ATRC : 23.74 (-0.54%)
AtriCure to Present at the JMP Securities Life Science Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it...

ATRC : 23.74 (-0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Support & Resistance

2nd Resistance Point 24.21
1st Resistance Point 23.98
Last Price 23.74
1st Support Level 23.50
2nd Support Level 23.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.